Physician profile
Shawn Smith
NPI 1285732156
$1,439.61
in general payments reported to CMS, 2019-2025
10 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $458 · 2023: $408 · 2024: $198 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $303.12 | 2023-2025 | Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $235.38 | 2022-2023 | Farxiga |
| Medtronic, INC. | $189.97 | 2023-2025 | Arctic Front Advance, Linq II |
| Amgen INC. | $150.75 | 2022-2025 | Repatha, Repatha |
| Abbott Laboratories | $124.83 | 2025 | 2nd Gen Centrimag Primary Console |
| Esperion Therapeutics, INC. | $124.47 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.83 | 2022 | |
| Inspire Medical Systems, INC. | $121.58 | 2024 | Inspire |
| Novartis Pharmaceuticals Corporation | $41.70 | 2023-2025 | |
| Abiomed | $23.98 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.